JW Pharmaceutical exports new Atopic dermatitis therapy technology to LEO Pharma

Published: 2018-08-29 09:33:00
Updated: 2018-08-29 16:29:57

JW Pharmaceutical(CEO Jae-Kwang Jeon & Young-Sup Shin) announced on the 24th that they signed a license-out agreement of its innovative Atopic dermatitis therapy ‘JW1601’ with LEO Pharma(CEO Gitte Aabo) having specialized competitiveness in the dermatologic field.

LEO Pharma, the top dermatologi...


- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.

Original Korean

Most Read News

Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.